Cingal vs Monovisc: Comparing Cartilage Treatments for Optimal Joint Health
Insights

Cingal vs Monovisc: Comparing Cartilage Treatments for Optimal Joint Health

London Cartilage Clinic

In the ever-evolving landscape of treatments for joint and cartilage issues, patients today have access to a range of non-surgical options designed to alleviate pain and improve mobility. Among these, Cingal and Monovisc stand out as leading choices for those seeking relief from the discomforts of osteoarthritis and similar conditions. This article delves into the distinctions between Cingal and Monovisc, providing essential insights to help you understand which treatment may best suit your needs.

Understanding Cingal and Monovisc

What is Cingal?

Cingal is a pioneering treatment that combines hyaluronic acid (HA) with corticosteroids to offer immediate and sustained relief from joint pain. The HA component works by restoring the natural lubrication of the joint, facilitating smoother movement, while the corticosteroid quickly reduces inflammation and pain. This dual-action formula makes Cingal a compelling option for those seeking fast and long-lasting relief.

What is Monovisc?

Monovisc, on the other hand, is a pure hyaluronic acid-based treatment designed to mimic the natural lubricating fluid in the joint. It's particularly favoured for its long-lasting lubrication effect, which can significantly reduce pain and improve joint functionality over time. Monovisc is a single-injection treatment, making it a convenient option for patients looking for a minimal intervention with enduring benefits. Who Are the Candidates? Candidates for either Cingal or Monovisc include individuals experiencing joint pain and mobility issues due to osteoarthritis, who have not responded adequately to traditional treatments such as physical therapy, oral medications, or other types of injections.

Comparing the Benefits

Cingal Benefits:

  • Offers rapid pain relief through its corticosteroid component.
  • Provides long-term lubrication and protection for the joint with HA.
  • Suitable for those needing immediate and sustained symptom management.

Monovisc Benefits:

  • Delivers prolonged joint lubrication with a single HA injection.
  • Avoids potential side effects associated with corticosteroids.
  • Beneficial for long-term joint health and mobility.

In conclusion, both Cingal and Monovisc offer effective relief for those suffering from the pain and mobility issues associated with osteoarthritis, with each having its unique benefits. By understanding the differences and consulting with your healthcare provider, you can choose the treatment that best aligns with your health needs and lifestyle. At the London Cartilage Clinic, we're dedicated to providing advanced, patient-centered care to help you achieve optimal joint health and a better quality of life. Book a Consultation

Frequently Asked Questions

  • Cingal's effects can last for up to six months, with immediate pain relief from the corticosteroid component. Monovisc also offers up to six months of relief, primarily through improved joint lubrication.
  • Both treatments can cause temporary injection site reactions such as pain, swelling, or bruising. Cingal, due to its corticosteroid component, may have additional considerations for those with specific health conditions.
  • Most patients can return to their regular activities within a few days following the injection, although it's advised to avoid strenuous activities for a short period.
  • Neither treatment can cure osteoarthritis, but both can significantly reduce symptoms and improve quality of life.
  • The choice depends on your specific condition, severity of symptoms, and personal preferences. Consulting with an orthopaedic specialist is essential to make an informed decision.
  • Coverage varies, so it's important to check with your insurance provider. Many insurers cover HA treatments for osteoarthritis under specific conditions.

Next steps

Where to go from here

These routes are selected from the topic and purpose of this article. They are guidance, not a diagnosis or treatment recommendation.

Learn more

Explore hyaluronic acid injection

Read the reviewed hyaluronic acid injection pathway, including who it may help and what happens next.

Talk to the team

Book a free discovery call

A non-medical call with the team to understand services and choose the right booking route.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.

London Cartilage Clinic

Latest Insights

Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.

Knee Cartilage Risk After a Partial ACL Tear
Joint Conditions
Eleanor Hayes

Knee Cartilage Risk After a Partial ACL Tear

Instability from a partial ACL tear—not the tear grade—drives cartilage damage by allowing cumulative abnormal movement that concentrates force on cartilage surfaces not designed for that loading.

Mosaicplasty for Talar Osteochondral Lesions
Foot & Ankle Cartilage
Eleanor Hayes

Mosaicplasty for Talar Osteochondral Lesions

Because the ankle bears full body weight across a small articular surface, even modest cartilage lesions impose disproportionate load, causing persistent pain unresponsive to physiotherapy. Mosaicplasty transplants living hyaline cartilage; at ten years it outperforms microfracture because true cartilage withstands load better than the fibrocartilage scar tissue created by stimulation techniques.

ChondroFiller for Focal Knee Cartilage Defects After Injury
ChondroFiller / Liquid Cartilage
Eleanor Hayes

ChondroFiller for Focal Knee Cartilage Defects After Injury

Focal cartilage lesions frequently accompany ACL and meniscus injuries, often left unaddressed as defects enlarge toward osteoarthritis; an injectable collagen scaffold produces mean functional gains of 30 points, exceeding the threshold at which patients report meaningful change.

Privacy & Cookies Policy
Free Discovery Call